AI assistant
Sending…
COGNITION THERAPEUTICS INC — Director's Dealing 2021
Nov 3, 2021
34027_dirs_2021-11-03_235329c8-d345-45fd-9c03-cf96771a9c6f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: COGNITION THERAPEUTICS INC (CGTX)
CIK: 0001455365
Period of Report: 2021-11-01
Reporting Person: RICHSTONE ELLEN B (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-11-01 | Stock Option (right to buy) | $12.1 | A | 16670 | Acquired | 2031-11-01 | Common Stock (16670) | Direct |
Footnotes
F1: The options will vest and become exercisable in thirty-six (36) equal monthly installments, subject to the reporting person's continuous service as of each such date.
More from COGNITION THERAPEUTICS INC
Regulatory Filings
2026
May 21
Interim / Quarterly Report
2026
May 8
Capital/Financing Update
2026
Mar 26
Annual Report
2026
Mar 26
Earnings Release
2026
Mar 26
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 5